Semax research overview

What the compound is

Semax is a synthetic peptide of seven amino acids derived from a fragment of adrenocorticotropic hormone (ACTH), modified so that it no longer carries the parent hormone's corticotropic activity profile.

How it appears in the research literature

Laboratory literature involving Semax is concentrated in central nervous system model systems, including work on neurotrophic factor expression. These are model-system observations only.

Related compounds in the same research category

The ATMI Labs Cognitive & Neuro category also lists Selank and Adamax. Comparative CNS study designs frequently reference more than one peptide from this group.

Handling and laboratory considerations

Lyophilized research peptides are generally handled as temperature-sensitive laboratory materials. Storage, reconstitution solvent, and container choice are determined by the receiving laboratory's own written protocol, not by the supplier.

Every ATMI Labs lot is released with batch documentation so that identity and purity figures used in a study can be traced back to the specific lot in hand.

• Confirm the lot identifier on the vial label against the published Certificate of Analysis.
• Record lot, strength, and receipt date in the laboratory inventory before use.
• Follow institutional handling, labeling, and disposal procedures for research chemicals.

Research use scope

Semax supplied by ATMI Labs is sold exclusively for laboratory research and analytical purposes. It is not a drug, supplement, cosmetic, or food, and it is not intended for human or veterinary use.

Nothing on this page describes therapeutic use, dosing, or clinical outcomes. Literature referenced in general terms describes laboratory and preclinical model systems only, and findings in such systems do not establish effects in humans.